COMMENTARY
Psychiatry in the Time of COVID: Credibility, Uncertainty, and Self-Reflection
Downloaded from http://journals.lww.com/jonmd by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 09/09/2021
David A. Adler, MD,* Matthew D. Erlich, MD,† Beth Goldman, MD, MPH,‡ Jeffrey Berlant, MD, PhD,§|| Matthew L. Edwards, MD,¶ Michael B. First, MD,† David W. Oslin, MD,# Samuel G. Siris, MD,** Rachel M. Talley, MD,†† Elizabeth S. Wagner, MD, MPH,‡‡ and Psychopathology Committee of the Group for Advancement of Psychiatry§§
Abstract: Public trust in the credibility of medicine and physicians has been severely tested amid the COVID-19 pandemic and growing sociopolitical fissures in the United States. Physicians are being asked to be ambassadors to the public of scientific information. Psychiatrists have an opportunity to help the public understand and accept a “new normal” during a time of such uncertainty. Using a case example, we review the impact of uncertainty and fear on scientific and medical credibility. Although the pandemic provides an opportunity for systemic change, the consequences of any change remain unknown. To help patients navigate the uncertainty, we conclude by offering four guidelines to clinicians: the public has little interest in understanding the scientific method; we need to acknowledge that we do not have all the answers; credibility and trustworthiness are linked to our ability to be trusted, believable messengers; and we can retain scientific credibility while acknowledging uncertainty. Key Words: COVID-19, coronavirus, SARS-CoV-2, pandemics, clinical adaptations to the pandemic, maintaining physician credibility, managing patient uncertainty, adaptations to care amidst social change, role of psychiatry during COVID-19 (J Nerv Ment Dis 2021;00: 00–00)
M
uch has (and will) be written about the impact of COVID-19 on societal transformation (i.e., massive societal reorganization, increasing tribalism, economic shifts, etc.) (Ahmad, 2020). In this upheaval, science as a whole and medicine specifically have suffered a crisis of credibility among segments of the public, and as such, an acceptance of professional “certainty” has been shaken. At the same time, psychiatrists, and physicians in general, are being asked to be ambassadors to the public of “scientific” information. The pandemic has amplified what we do not know as well as how to relate an ever-evolving science to a scared and, at times, skeptical public. But, as societal and scientific changes are being introduced at a breakneck pace with accelerated innovation, the reality is we do not know “what's next.” Add the fear factor and this conundrum of “trust what I have to say now, but I'm uncertain of what will follow” erodes that trust, alliances, and authority (Narayan et al., 2021). Psychiatry has an opportunity and a responsibility for helping the public understand and accept the “new normal.” However, it is impossible to both accurately define where we are now and where we are heading. As such, we find ourselves trying to define our present, uncertain about our future, and yet expected to speak from a position of authority. It is a difficult balancing act at a time of renewed concern about professional credibility. Consider Mr. B, a now 65-year-old former city public works employee, who was referred to Dr. Z in 2008 by his primary care physician (PCP) for evaluation and treatment of his road rage. Mr. B has had an impulse control disorder dating back to childhood with past legal issues. Nonetheless, he was in a successful long-term marriage with grown children. Mr. B had a stable job until a recent *Department of Psychiatry, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts; †Department of Psychiatry, New York State Psychiatric Institute/Columbia University Vagelos College of Physicians and Surgeons and New York Presbyterian, New York, New York; ‡Detroit, Michigan (retired); §Optum Idaho, Boise, Idaho; ||Canyon Manor Mental Health Rehabilitation, Novato, California; ¶Department of Psychiatry Stanford, Palo Alto, California; #Corporal Michael J. Crescenz Veterans Administration Medical Center, Philadelphia, Pennsylvania; **Department of Psychiatry, Donna and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, New York; ††Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; ‡‡Department of Psychiatry, Brown University Alpert Medical School, Providence, Rhode Island; and §§Group for Advancement of Psychiatry, New York, New York. Send reprint requests to David A. Adler, MD, Department of Psychiatry, Tufts Medical Center, 800 Washington St., #1007, Boston, MA 02111. E‐mail: dadler@tuftsmedicalcenter.org. Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved. ISSN: 0022-3018/21/0000–0000 DOI: 10.1097/NMD.0000000000001404
The Journal of Nervous and Mental Disease • Volume 00, Number 00, Month 2021 Copyright © 2021 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
www.jonmd.com
1